Clorox (NYSE:CLX) Issues FY 2027 Earnings Guidance

Clorox (NYSE:CLX) updated its FY 2027 earnings guidance on Monday morning. The company provided earnings per share (EPS) guidance of 5.700-6.000 for the period, compared to the consensus EPS estimate of 6.230. The company issued revenue guidance of $7.6 billion-$7.7 billion, compared to the consensus revenue estimate of $7.5 billion.

Clorox Price Performance

Shares of CLX opened at $104.26 on Wednesday. The company has a quick ratio of 0.65, a current ratio of 0.84 and a debt-to-equity ratio of 27.03. Clorox has a twelve month low of $84.70 and a twelve month high of $128.90. The stock has a market capitalization of $12.61 billion, a P/E ratio of 16.93 and a beta of 0.54. The company has a 50 day moving average of $95.73 and a 200-day moving average of $103.52.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Monday, August 3rd. The company reported $1.66 EPS for the quarter, topping analysts’ consensus estimates of $1.64 by $0.02. Clorox had a net margin of 8.74% and a return on equity of 764.12%. The business had revenue of $1.95 billion for the quarter, compared to analyst estimates of $1.91 billion. During the same quarter in the previous year, the firm posted $2.87 earnings per share. The firm’s revenue for the quarter was down 2.0% on a year-over-year basis. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS. As a group, equities research analysts forecast that Clorox will post 6.03 EPS for the current fiscal year.

Clorox Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 28th. Stockholders of record on Wednesday, August 12th will be paid a dividend of $1.25 per share. The ex-dividend date is Wednesday, August 12th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 4.8%. This is a positive change from Clorox’s previous quarterly dividend of $1.24. Clorox’s dividend payout ratio (DPR) is currently 81.17%.

Analysts Set New Price Targets

A number of analysts recently issued reports on CLX shares. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Clorox in a research report on Friday, July 10th. Zacks Research cut shares of Clorox from a “hold” rating to a “strong sell” rating in a research note on Tuesday, May 12th. Citigroup upped their target price on shares of Clorox from $97.00 to $100.00 and gave the company a “neutral” rating in a report on Tuesday. UBS Group lifted their price target on Clorox from $100.00 to $105.00 and gave the stock a “neutral” rating in a report on Tuesday. Finally, Royal Bank Of Canada dropped their price objective on Clorox from $132.00 to $127.00 and set a “sector perform” rating on the stock in a research note on Thursday, April 9th. Twelve analysts have rated the stock with a Hold rating and five have issued a Sell rating to the company’s stock. According to MarketBeat.com, Clorox has a consensus rating of “Reduce” and an average price target of $102.40.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. State Street Corp increased its holdings in Clorox by 3.5% in the 3rd quarter. State Street Corp now owns 8,434,277 shares of the company’s stock valued at $1,039,946,000 after buying an additional 282,794 shares during the period. Invesco Ltd. increased its stake in Clorox by 22.1% in the fourth quarter. Invesco Ltd. now owns 4,880,341 shares of the company’s stock valued at $492,085,000 after acquiring an additional 884,751 shares during the last quarter. Two Sigma Investments LP lifted its stake in Clorox by 33.8% during the third quarter. Two Sigma Investments LP now owns 1,740,175 shares of the company’s stock worth $214,564,000 after purchasing an additional 439,797 shares during the last quarter. Northern Trust Corp lifted its position in shares of Clorox by 4.8% during the 3rd quarter. Northern Trust Corp now owns 1,539,006 shares of the company’s stock worth $189,759,000 after buying an additional 70,783 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership lifted its stake in Clorox by 18.2% in the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 1,476,933 shares of the company’s stock valued at $182,106,000 after purchasing an additional 227,806 shares during the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.